Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
589,756
-
Share change
-
-3,211,872
-
Total reported value
-
$4,772,000
-
Price per share
-
$8.10
-
Number of holders
-
19
-
Value change
-
-$16,171,988
-
Number of buys
-
13
-
Number of sells
-
19
Institutional Holders of BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) as of Q3 2021
As of 30 Sep 2021,
BRIACELL THERAPEUTICS CORP - COM NEW (BCTX) was held by
19 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
589,756 shares.
The largest 10 holders included
VOLORIDGE INVESTMENT MANAGEMENT, LLC, Redmond Asset Management, LLC, TWO SIGMA INVESTMENTS, LP, GEODE CAPITAL MANAGEMENT, LLC, JANE STREET GROUP, LLC, Summit Trail Advisors, LLC, Virtu Financial LLC, Apollon Wealth Management, LLC, Eqis Capital Management, Inc., and Belvedere Trading LLC.
This page lists
19
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.